Vivani Medical VANI 深 沪
等待开盘 08-20 09:30:00 美东时间
1.39
-0.060
-4.14%
华盛通- 最 高1.53
- 今 开1.46
- 成交量 78.92万股
- 最 低 1.301
- 昨 收 1.45
- 总市值 1.25亿
- 52周最高 1.92
- 市盈率 静 --
- 换手率 0.87%
- 52周最低 0.9228
- 委 比 47.78%
- 总股本 9020.34万
- 历史最高 576.48
- 量 比 4.19
- 振 幅 15.79%
- 历史最低 0.7536
- 每 手 1
- 风险率 0.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vivani Medical Q2 EPS $(0.07) Beats $(0.08) Estimate
Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 41.67 percent increase over losses of $(0.12) per share from the same period last year.
08-14 04:21
ClearOne To Acquire Vivani Medical Subsidiary Cortigent For 12.5M Shares Of CLRO Worth ~$40.4M; ClearOne To File S-1 Seeking To Raise $10M-$15M
Vivani Medical, Inc. (NASDAQ:VANI) ("Vivani"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that it has entered into a definitive agreement and plan of merger (the "Agreement") among its wholly owned subsidiary Cortigent, Inc. ("Co...
07-02 20:03
美股大行评级 | 美银上调美光科技目标价从950美元升至1500美元，上调迈威尔科技目标价从240美元升至365美元
今日重点评级关注：摩根士丹利：维持杜邦"标配"评级，目标价从52美元升至156美元；蒙特利尔银行：维持Taysha Gene Therapies"跑赢大市"评级，目标价从10美元升至14美元
06-24 14:08
Lake Street Initiates Coverage On Vivani Medical with Buy Rating, Announces Price Target of $4
Lake Street analyst Thomas Flaten initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy rating and announces Price Target of $4.
06-23 22:24
Vivani Medical Q4 EPS $(0.09) Beats $(0.10) Estimate.
Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.10) by 10 percent. This is a 18.18 percent increase over losses of $(0.11) per share from the
03-27 04:49
Vivani's Brain Implant Helps Blind Patients See Light And Movement In 6-Year Study
Vivani Medical, Inc. (NASDAQ:VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that Cortigent, Inc. ("Cortigent"), its
01-29 20:35
